New Machine Learning Tool Improves Genetic Risk Prediction for Type 1 Diabetes

Researchers at UC San Diego developed a more accurate way to identify who might develop Type 1 diabetes by analyzing how multiple genes interact. The breakthrough could enable earlier detection and preventive approaches before the disease takes hold.

News report — unverified, pending corroboration

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

diagnosisscreeningstaging

Key takeaways

A new machine learning model called T1GRS can calculate genetic risk for Type 1 diabetes more accurately than current methods
The tool identified 13 previously unknown genetic locations linked to Type 1 diabetes, involving immune function, gene regulation, and blood sugar control
More accurate risk prediction could help identify children and adults who would benefit from preventive measures earlier
The research analyzed genetic data from over 20,000 people with Type 1 diabetes and nearly 800,000 without the condition

A More Complete Picture of Genetic Risk

Researchers at University of California San Diego have developed a machine learning tool that reads the complex language of genes more accurately to predict Type 1 diabetes risk. Called T1GRS, the model analyzes how multiple genes interact with each other—rather than looking at them in isolation—to calculate who is most likely to develop the autoimmune disorder.

The study, published in Nature Genetics in April 2026, demonstrates that this approach can identify high-risk individuals earlier than traditional genetic screening methods. Earlier identification could open the door to preventive interventions before Type 1 diabetes fully develops.

What the Data Revealed

The research team examined genetic information from over 20,000 people with Type 1 diabetes and nearly 800,000 people without the condition, all of European ancestry. They looked for genetic variants associated with disease risk and confirmed known risk factors at 79 different genetic locations on chromosomes.

More significantly, they discovered 13 new genetic locations previously not linked to Type 1 diabetes. These newly identified locations are involved in three key areas: how genes are regulated, how the immune system functions, and how the body controls blood sugar. This expanded map of genetic risk factors provides a more complete picture of the biological processes underlying Type 1 diabetes susceptibility.

The MHC Region: A Hotspot for Risk

One chromosomal region stood out in the research: the major histocompatibility complex (MHC) on chromosome 6. This area contains the strongest known genetic associations with Type 1 diabetes. The researchers performed detailed mapping of specific genetic variants in this region and found that blocks of co-inherited genetic information are particularly common in people with Type 1 diabetes.

By analyzing data from more than 29,000 people, the team uncovered several new variants in the MHC region that influence how the immune system functions and how genes are activated. Understanding these specific variants could help explain why some people carry much higher genetic risk than others.

What This Means for Earlier Detection

More accurate genetic risk prediction has practical implications for individuals and families. Identifying people at high genetic risk earlier in life could enable preventive approaches before Type 1 diabetes develops fully. This is particularly meaningful given that Type 1 diabetes involves autoimmune processes that may be slowed or delayed with early intervention.

The improved accuracy of T1GRS also opens possibilities for more personalized approaches to monitoring and care. Rather than treating all at-risk individuals the same way, clinicians could eventually tailor their approach based on an individual's specific genetic risk profile.

Evidence label

Origin: today.ucsd.edu (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.